Cerevel Therapeutics Holdings Inc (CERE) Live Stock Price, Forecast & News

Cerevel Therapeutics Holdings Inc
CERE
(Nasdaq - US)
N/A
42.11
-0.24 (-0.57%)
in:usd•As of: May 17, 2024 15:59 UTC -4
Open
42.26
High
42.30
Low
42.10

Stats
Prev. Close
42.35
Open
42.26
Day's Range
42.10 - 42.30
52 Week Range
19.59 - 43.59
YTD Change
-0.68%
1 Year Change
31.76%
Market Cap
7.67B
P/E Ratio
N/A
Volume
35,673
Beta
1.46
Sector
Health Technology
Industry
Pharmaceuticals Major
Economic CalendarAll Events
Time zone: GMT
Thursday, May 16th 2024
Time Currency Event Impact Actual Consensus Previous
15:30

USD
Fed Mester Speech
Medium
19:50

USD
Fed Bostic Speech
Medium
Friday, May 17th 2024
Time Currency Event Impact Actual Consensus Previous
14:15

USD
Fed Waller Speech
Medium
Saturday, May 18th 2024
Time Currency Event Impact Actual Consensus Previous
21:45

USD
Fed Kugler Speech
Medium
Sunday, May 19th 2024
Time Currency Event Impact Actual Consensus Previous
19:30

USD
Fed Chair Powell Speech
High
Monday, May 20th 2024
Time Currency Event Impact Actual Consensus Previous
12:45

USD
Fed Bostic Speech
Medium
13:00

USD
Fed Waller Speech
Medium
Latest News
InvezzMar 18, 2024
AI altcoins display upside momentum on Nvidia's GTC conference
CERE-0.57%
FETCH-AI-3.36%
THETA-TOKEN-1.84%
CNBCJan 6, 2024
Cramer names biopharma companies to watch as industry mergers start to pile up
CERE-0.57%
ABBV+1.30%
AZN-0.16%
Zacks Investment ResearchDec 19, 2023
Cerevel Therapeutics Holdings, Inc. (CERE)'s Technical Outlook is Bright After Key Golden Cross
CERE-0.57%
InvestopediaDec 7, 2023
AbbVie Buys Cerevel Therapeutics for $8.7B, Bolstering Neuroscience Portfolio
CERE-0.57%
ABBV+1.30%
InvezzDec 7, 2023
Cramer reacts to AbbVie buying Cerevel Therapeutics
CERE-0.57%
ABBV+1.30%
CNBC TelevisionDec 7, 2023
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
CERE-0.57%
ABBV+1.30%
Read All
Data Vendor:
Stocks
Loading
Loading

Thursday, May 16th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
15:30	USD	Fed Mester Speech	Medium
19:50	USD	Fed Bostic Speech	Medium

Friday, May 17th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
14:15	USD	Fed Waller Speech	Medium

Saturday, May 18th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
21:45	USD	Fed Kugler Speech	Medium

Sunday, May 19th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
19:30	USD	Fed Chair Powell Speech	High

Cerevel Therapeutics Holdings Inc

AI altcoins display upside momentum on Nvidia's GTC conference

Cramer names biopharma companies to watch as industry mergers start to pile up

Cerevel Therapeutics Holdings, Inc. (CERE)'s Technical Outlook is Bright After Key Golden Cross

AbbVie Buys Cerevel Therapeutics for $8.7B, Bolstering Neuroscience Portfolio

Cramer reacts to AbbVie buying Cerevel Therapeutics

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

Trade With A Regulated Broker